Diagnostic value of cerebrospinal fluid lactate as a biomarker of bacterial meningitis

Diagnostic value of cerebrospinal fluid lactate as a biomarker of bacterial meningitis

Main Article Content

Ricardo Rubio-Sánchez
Esperanza Lepe-Balsalobre

Abstract

Bacterial meningitis is a serious pathology that requires an accurate and early diagnosis. Increased leukocytes, with a predominance of polymorphonuclear cells, increased proteins, and hypoglycorrhachia are indicative of a bacterial etiology, although they do not always correlate with a definitive diagnosis. The aim of this study was to evaluate the usefulness of cerebrospinal fluid lactate as a biomarker of bacterial meningitis.


This is an observational and prospective study in which 706 cerebrospinal fluids from patients treated at the Virgen de Valme University Hospital (Seville, Spain) for 20 months were analyzed. Of the fluid analyzed, in 21 cases bacterial meningitis was diagnosed, in 31 cases bacterial meningitis was compatible, and in 654 cases bacterial meningitis was ruled out. The optimal cut-off point for lactate in cerebrospinal fluid was 3.0 mmol/L, with a sensitivity of 68%, a specificity of 98%, a positive predictive value of 79%, and a negative predictive value of 97%.


Lactate concentration, protein concentration, and the number of leukocytes in cerebrospinal fluid were significantly higher in patients with confirmed bacterial meningitis. The high negative predictive value of lactate is especially useful to rule out bacterial meningitis in sick patients. Lactate is the biomarker with the best diagnostic performance of all those analyzed, so we recommend its inclusion in the cerebrospinal fluid biochemical profile.

References

Buch K., Bodilsen J., Knudsen A., Larsen L., Helweg-Larsen J., Storgaard M., Brandt C., Wiese L., Ostergaard C., Nielsen H., Lebech A. & Danish Study Group for Infections in the Brain. (2018) Cerebrospinal fluid lactate as a marker to differentiate between community-acquired acute bacterial meningitis and aseptic meningitis/encephalitis in adults: a Danish prospective observational cohort study. Infect Dis, 50(7): 514-21. https://doi.org/10.1080/23744235.2018.1441539

Hussein K., Bitterman R., Shofty B., Paul M. & Neuberger A. (2017). Management of post-neurosurgical meningitis: narrative review. Clin Microbiol Infect, 23(9): 621-8. https://doi.org/10.1016/j.cmi.2017.05.013

Huy N.T., Thao N.T., Diep D.T., Kikuchi M., Zamora J. & Hirayama K. (2010) Cerebrospinal fluid lactate concentration to distinguish bacterial from aseptic meningitis: a systemic review and meta-analysis. Crit Care, 14(6): R240. https://doi.org/10.1186/cc9395

Jiménez P.E., Muñoz F., Murcia S. & Verdú A. (2011) Análisis descriptivo de las meningitis víricas en nuestro hospital. Características diferenciales entre niños y adultos. Neurol; 26(8): 468-73. https://doi.org/10.1016/j.nrl.2010.12.010

Sakushima K., Hayashino Y., Kawaguchi T., Jackson J.L. & Fukuhara S. (2011) Diagnostic accuracy of cerebrospinal fluid lactate for differentiating bacterial meningitis from aseptic meningitis: a meta-analysis. J Infect, 62(4): 255-62. https://doi.org/10.1016/j.jinf.2011.02.010

Sanaei A., Alizadeh S., Karimi A., Khalifeh M. & Abdolmajid S. (2017) Diagnostic value of lactate, procalcitonin, ferritin, serum-C-reactive protein, and other biomarkers in bacterial and viral meningitis: a cross-sectional study. Med (Baltimore), 96(35): e7637. https://doi.org/10.1097/MD.0000000000007637

World Medical Association. (2013) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA, 310(20): 2191-4. https://doi.org/10.1001/jama.2013.281053